Alginate-based long-acting injectable formulations: recent advances, biomedical applications, and translational challenges
- 12 November 2026
- journal article
- Published by Taylor & Francis in Therapeutic Delivery
- p. 1-19
Abstract
No abstract availableThis publication has 107 references indexed in Scilit:
- Fabrication of biodegradable polycaprolactone/chitosan nanoparticle/sodium alginate-based tablet implants for controlled doxorubicin releasePolymer Bulletin, 2025
- Platelet‐Rich Plasma Loaded Alginate‐Based Injectable Hydrogel for Meniscal Tear Repair: In Vivo Evaluation in Lapine ModelJournal of Biomedical Materials Research Part B: Applied Biomaterials, 2025
- Long-acting parenteral formulations of hydrophilic drugs, proteins, and peptide therapeutics: mechanisms, challenges, and therapeutic benefits with a focus on technologiesDrug Delivery and Translational Research, 2024
- Current State and Opportunities with Long-acting Injectables: Industry Perspectives from the Innovation and Quality Consortium “Long-Acting Injectables” Working GroupPharmaceutical Research, 2023
- Microspheres2023
- Tunable alginate hydrogels as injectable drug delivery vehicles for optic neuropathyJournal of Biomedical Materials Research Part A, 2022
- Diacerein Loaded Poly (Styrene Sulfonate) and Carbon Nanotubes Injectable Hydrogel: An Effective Therapy for Spinal Cord Injury RegenerationJournal of Cluster Science, 2022
- A review on multivesicular liposomes for pharmaceutical applications: preparation, characterization, and translational challengesDrug Delivery and Translational Research, 2021
- Polysaccharides of Microbial Origin2020
- An injectable alginate/extra cellular matrix (ECM) hydrogel towards acellular treatment of heart failureDrug Delivery and Translational Research, 2018